END STAGE LIVER DISEASE
Clinical trials for END STAGE LIVER DISEASE explained in plain language.
Never miss a new study
Get alerted when new END STAGE LIVER DISEASE trials appear
Sign up with your email to follow new studies for END STAGE LIVER DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
UCLA pioneers 'Delayed Tolerance' to end lifelong drug use after liver transplant
Disease control Recruiting nowThis study tests whether a donor stem cell infusion, given after a mild radiation and antibody treatment, can train the immune system to accept a liver transplant without needing lifelong anti-rejection drugs. Up to 12 adults who have had a well-functioning liver transplant from …
Matched conditions: END STAGE LIVER DISEASE
Phase: PHASE1, PHASE2 • Sponsor: University of California, Los Angeles • Aim: Disease control
Last updated May 01, 2026 16:00 UTC
-
Mayo clinic launches study to uncover liver transplant disparities
Knowledge-focused Recruiting nowThis study from Mayo Clinic will look at 100 people with end-stage liver disease to understand why some are less likely to be placed on a transplant waiting list or receive a transplant. The goal is to find ways to make the transplant process fairer for everyone.
Matched conditions: END STAGE LIVER DISEASE
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Apr 30, 2026 15:49 UTC
-
Can a facebook post save your life? new study tests social media for organ donors
Knowledge-focused Recruiting nowThis study is testing a web-based app that helps people waiting for a kidney or liver transplant share their story on social media to find a living donor. The goal is to see if this approach increases the number of potential donors who come forward and leads to more transplants. …
Matched conditions: END STAGE LIVER DISEASE
Phase: NA • Sponsor: Johns Hopkins University • Aim: Knowledge-focused
Last updated Apr 28, 2026 13:02 UTC